Learn from GSK experts to identify significant challenges and practical solutions for deploying and maintaining platform analytical procedures throughout different development and lifecycle stages.
Opportunities and challenges from ICH Q2 (2) and Q14 for the analytical lifecycle
On-Demand Presentation | With experts from GSK
Regulatory expectations for your HCP analysis: meet USP <1132.1> to enhance the quality of MS-based data
On-Demand | Incl. panellist from U.S. Pharmacopeia (USP)
LIMS as Part of the Application Landscape for Manufacturing
On-Demand Presentation by Paul Shrevel (Solution Too)
Explore the key success factors and implementation challenges in LIMS deployment
On-Demand Presentation by Ramon de Groot (Limes Lab Support)
Beyond Accuracy and Precision: Total Analytical Error and Linearity in ICH Q2 Revision 2
On-Demand Presentation by Dr. Pierre Lebrun (Cencora – PharmaLex)
From ATP to Acceptance Criteria: Mastering ICH Q2 Revision 2
On-Demand Presentation by Dr. Joachim Ermer (Ermer Quality Consulting)
Patient-Centric Specification Setting: Beyond Batch Data
On-Demand Presentation by Dr. Simona Cianetti (GSK)
Statistically Sound Specification Setting – A Practical Approach Consistent with ICH Q6B and Q14
On-Demand Presentation by Dr Eric Rozet (GSK)
Regulatory science behind drug substance & drug product specifications of monoclonal antibodies
On-Demand Presentation by Dr. Patanachai “Kong” Limpikirati (Chulalongkorn University)
Advertisement
Advertisement
Advertisement




















